Neuropeptide Y and sleep

Sleep Medicine Reviews

Volumn 14, Issue 3, 2010, Pages 161-165

  Dyzma, Michal ^a   Boudjeltia, Karim Z ^a   Faraut, Brice ^a   Kerkhofs, Myriam ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Basal Forebrain (BF); CRH; NPY; Sleep regulation

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROHORMONE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; RECEPTOR SUBTYPE;

ADOLESCENT; AMYGDALOID NUCLEUS; ANXIETY; BRAIN CORTEX; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CHILD; CIRCADIAN RHYTHM; FOOD INTAKE; HORMONE RELEASE; HUMAN; HYPNOSIS; HYPOTHALAMUS; LOCUS CERULEUS; METABOLIC REGULATION; NONHUMAN; NONREM SLEEP; REGULATORY MECHANISM; REM SLEEP; REVIEW; SLEEP; SLEEP WAKING CYCLE; STRESS; THERMOREGULATION;

ANIMALS; BRAIN; BRAIN MAPPING; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; EATING; ELECTROENCEPHALOGRAPHY; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; SLEEP; SYMPATHETIC NERVOUS SYSTEM; WAKEFULNESS;

EID: 77950923042     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2009.09.001     Document Type: Review

References (53)

1. Tatemoto K., Carlquist M., and Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296 5858 (1982) 659-660
2. Blundell T.L., Pitts J.E., Tickle I.J., Wood S.P., and Wu C.W. X-ray analysis (1.4-A resolution) of avian pancreatic polypeptide: small globular protein hormone. Proc Natl Acad Sci U S A 78 (1981) 4175-4179
3. Fuhlendorff J., Johansen N.L., Melberg S.G., Thogersen H., and Schwartz T.W. The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors. J Biol Chem 265 20 (1990) 11706-11712
4. Silva A.P., Cavadas C., and Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326 1-2 (2002) 3-25
5. Wood S.P., Pitts J.E., Blundell T.L., Ticke I.J., and Jenkins J.A. Purification, crystallisation and preliminary X-ray studies on avian pancreatic polypeptide. Eur J Biochem 78 1 (1977) 119-126
6. Glover I., Haneef I., Pitts J., Woods S., Moss D., and Tickle I. Bundell T conformational flexibility in a small globular hormone: X-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers 22 1 (1983) 293-304
7. Glover I.D., Barlow D.J., Pitts J.E., Wood S.P., Tickle I.J., and Blundell T.L. Conformational studies on the pancreatic polypeptide hormone family. Eur J Biochem 142 2 (1984) 379-385
8. Monks S.A., Karagianis G., Howlett G.J., and Norton R.S. Solution structure of human neuropeptide Y. J Biomol NMR 8 4 (1996) 379-390
9. Darbon H., Bernassau J.M., Deleuze C., Chenu J., Roussel A., and Cambillau C. Solution conformation of human neuropeptide Y by 1H nuclear magnetic resonance and restrained molecular dynamics. Eur J Biochem 209 (1992) 765-771
10. Bettio A., Dinger M.C., and Beck-Sickinger A.G. The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold. Protein Sci 11 7 (2002) 1834-1844
11. Baker E., Hort Y.J., Ball H., Sutherland G.R., Shine J., and Herzog H. Assignment of the human neuropeptide Y gene to chromosome 7p15.1 by nonisotopic in situ hybridization. Genomics 26 1 (1995) 163-164
12. Takeuchi T., Gumucio D.L., Yamada T., Meisler M.H., Minth C.D., and Dixon J.E. Genes encoding pancreatic polypeptide and neuropeptide Y are on human chromosomes 17 and 7. J Clin Invest 77 3 (1986) 1038-1041
13. Grouzmann E., and Brakch N. NPY processing in neuronal and non-neuronal tissues by proconvertases. In: Zukowska Z., and Feuerstein G.Z. (Eds). The NPY family of peptides in immune disorders, inflammation, angiogenesis, and cancer (2005), Birkhauser Verlag, Basel/Boston/Berlin 63-74
14. Larhammar D., Ericsson A., and Persson H. Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci U S A 84 7 (1987) 2068-2072
15. Higuchi H., Yang H.Y., and Sabol S.L. Rat neuropeptide Y precursor gene expression. mRNA structure, tissue distribution, and regulation by glucocorticoids, cyclic AMP, and phorbol ester. J Biol Chem 263 13 (1988) 6288-6295
16. Williams A.G., Hargreaves A.C., Gunn-Moore F.J., and Tavaré J.M. Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cgamma and Shc binding sites on its receptor, TrkB. Biochem J 333 (1998) 505-509
17. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., and O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15 4 (1985) 1159-1181
18. Palkovits M. Peptidergic neurotransmitters in the endocrine hypothalamus. Ciba Found Symp 168 (1992) 3-10
19. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 92 1-2 (2007) 263-271
20. The biology of neuropeptide Y and related peptides. In: Colmers W.F., and Wahlestedt C. (Eds). Contemporary neuroscience (1993), Humana Press
21. Dumont Y., Martel J.C., Fournier A., St Pierre S., and Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol 38 2 (1992) 125-167
22. Terenghi G., Polak J.M., Hamid Q., O'Brien E., Denny P., and Legon S. Localization of neuropeptide Y mRNA in neurons of human cerebral cortex by means of in situ hybridization with a complementary RNA probe. Proc Natl Acad Sci U S A 84 20 (1987) 7315-7318
23. Silva A.P., Kaufmann J.E., Vivancos C., Fakan S., Cavadas C., and Shaw P. Neuropeptide Y expression, localization and cellular transducing effects in HUVEC. Biol Cell 97 6 (2005) 457-467
24. Cavadas C., Silva A.P., Mosimann F., Cortin M.D., Ribiero C.A., Brunner H.R., et al. NPY regulates catecholamine secretion from human adrenal chromaffin cells. J Clin Endocrinol Metab 86 12 (2001) 5956-5963
25. Ericsson A., Schalling M., McIntyre K.R., Lundberg J.M., Larhammar D., and Seroogy K. Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. Proc Natl Acad Sci U S A 84 16 (1987) 5585-5589
26. Myers A.K., Farhat M.Y., Vaz C.A., Keiser H.R., and Zukowska-Grojec Z. Release of immunoreactive-neuropeptide by rat platelets. Biochem Biophys Res Commun 155 1 (1988) 118-122
27. Ericsson A., Hemsen A., Lundberg J.M., and Persson H. Detection of neuropeptide Y-lik e immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. Exp Cell Res 192 2 (1991) 604-611
28. Grouzmann E., and Brakch N. In: Zukowska Z., and Feuerstein G.Z. (Eds). Function, distribution and molecular pharmacology of NPY-family receptors, in the NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis, and Cancer (2005), Birkhauser Verlag, Basel/Boston/Berlin 29-62
29. Lundberg J.M., Terenius L., Hökfelt T., and Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42 2 (1983) 167-172
30. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Res 50 1 (1998) 143-150
31. Holliday N.D., Michel M.C., and Cox H.M. In: Michel M.C. (Ed). NPY Receptor Subtypes and Their Signal Transduction, in Neuropeptide Y and Related Peptides (2004), Springer 46-67
32. Lockinger A., Köberle D., Konig P.S., Saria A., Herold M., Cornélissen G., et al. Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns. Peptides 25 (2004) 533-542
33. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
34. Shah S.H., Freedman N.J., Zhang L., Crosslin D.R., Stone D.H., Haynes C., et al. Neuropeptide Y gene polymorphism confer risk of early-onset atherosclerosis. PLoS Genet 5 1 (2009) e1000318
35. Heilig M., and Murison R. Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19 (1987) 221-231
36. Jolicoeur F.B., Michaud J.N., Rivest R., Menard D., Gaudin D., Fournier A., et al. Neurobehavioral profile of neuropeptide Y. Brain Res Bull 26 2 (1991) 265-268
37. Ida T., Nakahara K., Katayama T., Murakami N., and Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 821 2 (1999) 526-529
38. Stanley B.G., and Leibowitz S.F. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35 26 (1984) 2635-2642
39. Britton K.T., Southerland S., Van Uden E., Kirby D., Rivier J., and Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacol 132 1 (1997) 6-13
40. Sajdyk T.J., Vandergriff M.G., and Gehlert D.R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368 2-3 (1999) 143-147
41. Zini I., Merlo Pich E., Fuxe K., Lenzi P.L., Agnati L.F., and Harfstrans A. Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle. Acta Physiol Scand 122 1 (1984) 71-77
42. Fuxe K., Agnati L.F., Harstrand A., Zini I., Tatemoto K., and Dich E.M. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118 2 (1983) 189-192
43. Duque A., Tepper J.M., Detari L., Ascoli G.A., and Zaborsky L. Morphological charaterization of electrophysiologically and immunohistochemically identified basal forebrain cholinergic and neuropetide Y-containing neurons. Brain Struct Funct 212 1 (2007) 55-73
44. Toth A., Hajnik T., Zaborsky L., and Détari L. Effect of basal forebrain neuropeptide Y administration on sleep and spontaneous behavior in freely moving rats. Brain Res Bull 72 4-6 (2007) 293-301
45. Szentirmai E., and Krueger J.M. Central administration of neuropeptide Y induces wakefulness in rats. Am J Physiol Regul Integr Comp Physiol 291 2 (2006) R473-R480
46. Ehlers C.L., Somes C., Lopez A., Kirby D., and Rivier J.E. Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy. Neuropsychopharmacology 17 (1997) 34-43
47. Zaborsky L. The molecular organization of brain systems. Basal forebrain: the last frontier. Prog Brain Res 136 (2002) 359-372
48. Ehlers C.L., Somes C., Seifritz E., and Rivier J.E. CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depress Anxiety 6 1 (1997) 1-9
49. Li B.H., Xu B., Rowland N.E., and Kalra S.P. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res 665 2 (1994) 277-284
50. Antonijevic I.A., Murck H., Bohlhalter S., Frieboes R.M., Holsboer F., and Steiger A. Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men. Neuropharmacology 39 8 (2000) 1474-1481
51. Held K., Antonijevic I.A., Murck H., Künzel H., and Steiger A. Neuropeptide Y (NPY) Shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 31 1 (2009) 100-107
52. Steiger A. Sleep and endocrinology. J Inter Med 254 (2003) 13-22
53. Barcelo A., Barbé F., Llompart E., de la Pena M., Duran-Cantolla J., and Ladaria A. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome. Am J of Resp Crit Care Med 171 (2005) 183-187